Skip to content
HowShorted

Paratek Pharmaceuticals, Inc. short interest in 2023

In 2023, Paratek Pharmaceuticals, Inc.'s disclosed short interest ran from 6.31% of shares outstanding on 13 Jan 2023 to 4.81% on 15 Sep 2023, a change of -1.50 percentage points. The year's high was 8.57% on 28 Apr 2023 and its low 4.42% on 15 Jun 2023, averaging 6.18% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 21.51 days on 15 Feb 2023. Full history: Paratek Pharmaceuticals, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023

Aggregate net short position time series for Paratek Pharmaceuticals, Inc. in 2023

2023 in figures

Start of year
6.31% (13 Jan 2023)
End of year
4.81% (15 Sep 2023)
Change
-1.50 pp
High
8.57% (28 Apr 2023)
Low
4.42% (15 Jun 2023)
Average
6.18%
Highest days to cover
21.51 (15 Feb 2023)
SEC filings marked
3

Every report in 2023

Paratek Pharmaceuticals, Inc. short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 20236.31%11.20
31 Jan 20236.29%12.29
15 Feb 20236.33%21.51
28 Feb 20236.38%15.99
15 Mar 20236.51%14.09
31 Mar 20237.63%2.2110-K filed
14 Apr 20238.27%6.03
28 Apr 20238.57%7.48
15 May 20237.77%10.2610-Q filed
31 May 20237.62%21.17
15 Jun 20234.42%1.00
30 Jun 20234.44%2.70
14 Jul 20235.06%5.48
31 Jul 20235.08%6.59
15 Aug 20234.93%7.7010-Q filed
31 Aug 20234.60%8.04
15 Sep 20234.81%6.27

See also: Paratek Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.